Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.
Channels (Austin). 2023 Dec;17(1):2253102. doi: 10.1080/19336950.2023.2253102. Epub 2023 Oct 8.
Many neurological conditions exhibit synaptic impairments, suggesting mechanistic convergence. Additionally, the pannexin 1 (PANX1) channel and signaling scaffold is linked to several of these neurological conditions and is an emerging regulator of synaptic development and plasticity; however, its synaptic pathogenic contributions are relatively unexplored. To this end, we explored connections between synaptic neurodevelopmental disorder and neurodegenerative disease susceptibility genes discovered by genome-wide association studies (GWASs), and the neural PANX1 interactome (483 proteins) identified from mouse Neuro2a (N2a) cells. To identify shared susceptibility genes, we compared synaptic suggestive GWAS candidate genes amongst autism spectrum disorders, schizophrenia, Parkinson's disease, and Alzheimer's disease. To further probe PANX1 signaling pathways at the synapse, we used bioinformatics tools to identify PANX1 interactome signaling pathways and protein-protein interaction clusters. To shed light on synaptic disease mechanisms potentially linking PANX1 and these four neurological conditions, we performed additional cross-analyses between gene ontologies enriched for the PANX1 synaptic and disease-susceptibility gene sets. Finally, to explore the regional specificity of synaptic PANX1-neurological condition connections, we identified brain region-specific elevations of synaptic PANX1 interactome and GWAS candidate gene set transcripts. Our results confirm considerable overlap in risk genes for autism spectrum disorders and schizophrenia and identify potential commonalities in genetic susceptibility for neurodevelopmental disorders and neurodegenerative diseases. Our findings also pinpointed novel putative PANX1 links to synaptic disease-associated pathways, such as regulation of vesicular trafficking and proteostasis, warranting further validation.
许多神经疾病表现出突触损伤,表明其机制具有趋同性。此外,连接蛋白 1(PANX1)通道和信号支架与其中的几种神经疾病有关,是突触发育和可塑性的新兴调节因子;然而,其突触致病作用相对未知。为此,我们探索了全基因组关联研究(GWASs)发现的与突触神经发育障碍和神经退行性疾病易感性相关的基因之间的联系,以及从小鼠 Neuro2a(N2a)细胞中鉴定出的神经 PANX1 相互作用组(483 种蛋白)。为了鉴定共同的易感性基因,我们比较了自闭症谱系障碍、精神分裂症、帕金森病和阿尔茨海默病中与突触相关的 GWAS 候选基因。为了进一步研究突触中 PANX1 信号通路,我们使用生物信息学工具鉴定了 PANX1 相互作用组信号通路和蛋白质-蛋白质相互作用簇。为了阐明潜在连接 PANX1 和这四种神经疾病的突触疾病机制,我们对富含 PANX1 突触和疾病易感性基因集的基因本体论进行了额外的交叉分析。最后,为了探索突触 PANX1-神经疾病连接的区域特异性,我们鉴定了具有突触 PANX1 相互作用组和 GWAS 候选基因集转录物的脑区特异性升高。我们的研究结果证实了自闭症谱系障碍和精神分裂症的风险基因存在相当大的重叠,并确定了神经发育障碍和神经退行性疾病遗传易感性的潜在共性。我们的研究结果还指出了新型 PANX1 与突触疾病相关途径的潜在联系,如囊泡运输和蛋白质稳态的调节,值得进一步验证。